LISKANTIN

This brand name is authorized in Germany, Estonia, Lithuania

Active ingredients

The drug LISKANTIN contains one active pharmaceutical ingredient (API):

1 Primidone
UNII 13AFD7670Q - PRIMIDONE

Primidone is an anticonvulsant. Although the precise mode of action of primidone is unknown, in common with other anticonvulsants, effects on the neuronal membrane particularly with respect to alteration of ionic fluxes are likely to play a fundamental role.

Read about Primidone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N03AA03 Primidone N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AA Barbiturates and derivatives
Discover more medicines within N03AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 01358519, 01358525, 04897168, 04897174
Country: EE Ravimiamet Identifier(s): 1009336, 1077027
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1004588

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.